Related Experiment Video
Updated: Aug 14, 2026

Murine Ileocolic Bowel Resection with Primary Anastomosis
Published on: October 29, 2014
[Minimally invasive surgery and Crohn disease]
U Hildebrandt1, K W Ecker, G Feifel
1Abteilung für Allgemeine Chirurgie, Abdominal- und Gefässchirurgie, Universitätskliniken des Saarlandes, Homburg.
Laparoscopic surgery for Crohn's disease, particularly ileocecal resections, offers low morbidity when indicated early. While effective for elective cases, acute conditions remain excluded, with a conversion rate of 0-22% due to inflammatory complications.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Minimally Invasive Surgery
Context:
- Crohn's disease often requires surgical intervention, with ileocecal resection being a common procedure.
- Early surgical indication in Crohn's disease is associated with reduced morbidity and mortality.
- Laparoscopic approaches are increasingly utilized for elective Crohn's disease surgeries.
Purpose:
- To evaluate the safety and efficacy of laparoscopic resections in patients with Crohn's disease.
- To determine the feasibility of laparoscopic surgery for various types of Crohn's disease resections.
- To analyze conversion rates and reasons for conversion from laparoscopic to open surgery.
Summary:
- A series of 222 laparoscopic resections for Crohn's disease included ileocecal, anastomotic, and colonic resections, among others.
- Laparoscopic surgery is suitable for elective procedures in early-stage Crohn's disease, excluding acute conditions like obstruction or perforation.
- Conversion rates ranged from 0-22%, primarily due to inflammatory masses, severe inflammation, or fistulas.
Impact:
- Laparoscopic techniques, including ileocecal resection, can be performed with low morbidity and mortality when indicated promptly.
- Advancements in laparoscopic surgery may expand its application to more complex Crohn's disease cases, including fistula closure and colonic resections.
- Successful laparoscopic resections contribute to shorter postoperative hospital stays (5-8 days) and potentially reduced reoperation rates.
More Related Videos
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Crohn's Disease

